Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Treat Rev. 2002 Jun;28(3):137-40.

Cancer and thromboembolic disease: pathogenic mechanisms.

Author information

1
Hamilton Health Sciences, Henderson Site, Ont, Canada L8V 1C3. alee@mcmaster.ca

Abstract

Almost all types of cancer are associated with an activation of coagulation. However, elevation of haemostatic markers of coagulation does not predict venous thrombosis. Multiple and interdependent processes between the tumour and the patient induce a hypercoagulable state. Tumour procoagulant activity, host inflammatory responses and extrinsic factors are involved. Tumour cells express the procoagulants, tissue factor and cancer procoagulant. They also release inflammatory cytokines and vascular endothelial growth factor, substances that enhance procoagulant activity and angiogenesis. Tumour-induced coagulation is intrinsically involved with tumour growth, angiogenesis and metastasis.

PMID:
12234564
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center